1.
Krawczyk P, Szreder B, Chodań T, Lewicka M, Łapaj M, Pietrzyk P, et al. THE EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR THERAPY IN THE TREATMENT OF HCV INFECTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE – A REVIEW OF CURRENT LITERATURE. IJITSS [Internet]. 2026 May 18 [cited 2026 May 25];1(2(50). Available from: https://rspublisher.org/index.php/ijitss/article/view/5234